Clinician Innovation in Action

Impathiq™ is a clinical decision support company founded in 2016 by emergency medicine physicians dedicated to solving the complex and costly challenge of chest pain evaluations in the emergency department. With the introduction of HEART Pathway™ in 2017, Impathiq became the industry leader in validated decision support designed to risk-stratify patients for early discharge, benefitting both the patient and health system with enhanced safety, lower costs, and improved quality of care.

Today’s Solutions are Inefficient. Most health systems rely on static, non-integrated protocols for chest pain, making it challenging to monitor usage, maintain uniformity of care, and ensure compliance. By contrast Impathiq's decision support platform enables health systems to create advanced, fully integrated care pathways that offer clarity and transparency to providers and administrators. Impathiq Clinical Decision Support (CDS) offers a sophisticated and easy-to-use clinical decision support platform for the management and care of chest pain patients in the ED. Embedded within your hospital’s EMR, Impathiq CDS puts your cardiac protocol at the fingertips of your physicians at the exact time of need. Saving Hospitals and Clinicians valuable time and money.

For more information, email to contact@impathiq.com

Which surgical instruments do you actually need? The automated Mente surgical instrument tracking process allows each surgical instrument to be recorded as it enters the surgical field.  This ensures immediate and accurate identification of exactly when, and for how long, that instrument is used. Applied across the entire suite of surgical instruments, our unique data stream provides detailed statistics on instrument usage by procedure, operating room, time, surgeon, and surgical instrument trays.  In our pilot studies, instrument supply was reduced by 50%.  This means substantial cost savings for the hospital, faster operating room setup times, and reduced instrument tray weights. In subsequent operations, none of the eliminated instruments were requested by the surgeon. The data is gathered automatically, minimizing the impact on the busy clinical operation.  

Mente powers its products by tracking surgical instruments in the operating room, creating dependable, real-time data streams that transform OR resource management.  The company’s mission is to use predictive analytics to create the best surgical experience at the lowest cost for the hospital, the surgical team, and the patient.  The automated Mente tracking process does not rely on employing manual observers or surgical committees to provide anecdotal information on instrument usage for optimization programs. The system and data collection service operates continuously as surgeries take place. The resulting information and optimization techniques stay in-house, unlike the fleeting nature of consultant engagements.  With this solution, Mente envisions a surgery where the care team has exactly what they need, when they need it.  

For more information: weshill@mentemedical.com 

Perfusio Corp. is a medical device company in Greenville, North Carolina, that has developed an FDA-cleared, Class II technology platform for surgical imaging that provides surgeons instantaneous data and visual images of blood flow distribution (flow and perfusion) in tissues, up to a depth of 4-5mm, during surgery to augment medical decisions. Perfusio’s Certes™ utilizes the combination of near-infrared and visible light with laser speckle imaging to produce “multi-spectral physiologic visualization, “MSPV” platform technology. It does not require patient contact, dyes, or ionizing radiation, so it is safe for patients and clinicians. The company’s interoperative technology is driven by artificial intelligence and advanced analytics to improves surgical efficiency and patient outcomes, avoids preventable surgical errors and complications, and creates significant healthcare savings while also saving lives.

Up to 15% of key surgical procedures have major complications, including death, that many times results from poor visualization of blood flow and tissue perfusion during the surgery. Visible light can only show the surface anatomy, so surgeons must make clinical decisions with incomplete information.

Certes™ from Perfusio resolves this dilemma by providing real-time visualization of blood flow and tissue perfusion during surgery. This additional knowledge enables surgeons to make better-informed and more accurate decisions at critical junctures. The new knowledge generated by Certes™ remains accessible after the procedure in the Perfusio-ARMUS Cloud Repository via a secure surgical web portal. This aggregate procedural and associated patient outcome data form the basis for future real-time individual patient predictive analytics.

For more information, contact B. Tucker, monte.tucker@perfusio.com or 252-656-0404 ext. 1006 (offfice)